Form 4: MapLight Therapeutics Insider Buys Shares
Insider Transaction (Form 4)
Catalyst4, Inc. reported changes in beneficial ownership of MapLight Therapeutics, Inc. common stock on August 14, 2026.
Summary
- Open-market purchase: acquired 4,400,000 Voting Common Stock at $11.38 ($50,072,000) on August 14, 2026; holds 25,306,689 after (Indirect).
- Open-market purchase: acquired 2,928,686 Warrants (right to buy) at $11.38 ($33,328,154) on August 14, 2026; holds 2,928,686 after (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $83,400,154, committing personal capital to the stock.
Insider Transactions
Catalyst4, Inc. — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Open-market purchase | Voting Common Stock | 4,400,000 | $11 | $50.1M | 25,306,689 |
| 2026-08-14 | Open-market purchase | Warrants (right to buy) | 2,928,686 | $11 | $33.3M | 2,928,686 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Open-market purchase (4,400,000 shares) |
| 2026-08-14 | Open-market purchase (2,928,686 shares) |
Keywords
insider transaction, Form 4, MLPT, MapLight Therapeutics, Inc., bullish, Catalyst4, Inc.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.